Search Results - "Alabdullah, Muslim"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line by al Alabdullah, Muslim Abdulrazzaq A., Goodarzi, Mohammad Taghi, Homayouni Tabrizi, Masoud

    Published in Scientific reports (26-06-2024)
    “…Entrapping phytochemical bioactive compounds into nano-structured biocompatible polymers has been successfully utilized for improving cancer treatment…”
    Get full text
    Journal Article
  2. 2
  3. 3

    RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers by Alblihy, Adel, Alabdullah, Muslim L., Toss, Michael S., Algethami, Mashael, Mongan, Nigel P., Rakha, Emad A., Madhusudan, Srinivasan

    Published in Molecular biomedicine (30-12-2020)
    “…Intrinsic or acquired resistance seriously limits the use of platinating agents in advanced epithelial ovarian cancers. Increased DNA repair capacity is a key…”
    Get full text
    Journal Article
  4. 4

    Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers by Alblihy, Adel, Alabdullah, Muslim L, Ali, Reem, Algethami, Mashael, Toss, Michael S, Mongan, Nigel P, Rakha, Emad A, Madhusudan, Srinivasan

    Published in Biomedicines (08-01-2021)
    “…Platinum resistance seriously impacts on the survival outcomes of patients with ovarian cancers. Platinum-induced DNA damage is processed through DNA repair…”
    Get full text
    Journal Article
  5. 5

    ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity by Ali, Reem, Alabdullah, Muslim, Miligy, Islam, Normatova, Makhliyo, Babaei-Jadidi, Roya, Nateri, Abdolrahman S, Rakha, Emad A, Madhusudan, Srinivasan

    Published in Cells (Basel, Switzerland) (18-10-2019)
    “…Ataxia-telegiectasia mutated (ATM), phosphatase and tensin homolog (PTEN), and p85α are key tumour suppressors. Whether ATM regulates PTEN expression and…”
    Get full text
    Journal Article
  6. 6

    Exploring the Role of Cell Signalling and Dna Damage Pathways in Primary Surgically Resected Ovarian Cancer by Alabdullah, Muslim

    Published 01-01-2021
    “…Background: Ovarian cancer (OC) is the most lethal gynaecologic malignancy. It is a heterogeneous disease at the molecular, histological and clinical levels…”
    Get full text
    Dissertation
  7. 7

    PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers by Ali, Reem, Alabdullah, Muslim, Alblihy, Adel, Miligy, Islam, Mesquita, Katia A., Chan, Stephen YT, Moseley, Paul, Rakha, Emad A., Madhusudan, Srinivasan

    Published in Cancer letters (28-01-2020)
    “…PARP1 inhibitor (Niraparib, Olaparib, Rucaparib) maintenance therapy improves progression-free survival in platinum sensitive sporadic epithelial ovarian…”
    Get full text
    Journal Article
  8. 8

    ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers by Mesquita, Katia A., Alabdullah, Muslim, Griffin, Michaela, Toss, Michael S., Fatah, Tarek M.A. Abdel, Alblihy, Adel, Moseley, Paul, Chan, Stephen Y.T., Rakha, Emad A., Madhusudan, Srinivasan

    Published in Gynecologic oncology (01-05-2019)
    “…PARP inhibitor maintenance therapy in platinum sensitive sporadic ovarian cancers improves progression free survival. However, biomarker for synthetic…”
    Get full text
    Journal Article
  9. 9
  10. 10